Early diagnosis of Murray Valley encephalitis by reverse transcriptase-polymerase chain reaction

Pathology

Volumn 32, Issue 1, 2000, Pages 49-51

  McMinn, Peter C ^a   Carman, Paul G ^a   Smith, David W ^b  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Murray Valley encephalitis; Polymerase chain reaction; Rapid diagnosis

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISABILITY; DISEASE SEVERITY; EARLY DIAGNOSIS; HUMAN; KUNJIN VIRUS; MALE; MURRAY VALLEY VIRUS; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SUPERINFECTION; VIRUS ENCEPHALITIS;

EID: 0034000651     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130200104583     Document Type: Article

References (14)

1. 1. Mackenzie JS, Smith DW, Broom AK, et al. Australian encephalitis in Western Australia, 1978-1991. Med J Aust 1993; 158: 591-5.
2. 2. Mackenzie JS, Lindsay MD, Coelen RJ, et al. Arboviruses causing human disease in the Australasian zoogeographic region. Arch Virol 1994; 136: 447-67.
3. 3. Smith DW, Broom AK, Keil AD, et al. Murray Valley encephalitis acquired in Western Australia. Med J Aust 1991; 154: 845-6.
4. 4. Burrow JNC, Whelan PI, Kilburn CJ, et al. Australian encephalitis in the Northern Territory: clinical and epidemiological features, 1987-1996. Aust NZ J Med 1998; 28: 590-6.
5. 5. French EL. Murray Valley encephalitis: Isolation and characterisation of the aetiological agent. Med J Aust 1952; 1: 100-3.
6. 6. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958; 7: 561-73.
7. 7. Westaway EG, Della-Porta AJ, Reedman BM. Specificity of IgM and IgG antibodies after challenge with antigenically related togaviruses. J Immunol 1974; 112: 656-63.
8. 8. Meiyu F, Huosheng C, Cuihua C, et al. Detection of flaviviruses by reverse transcriptase-polymerase chain reaction with the universal primer set. Microbiol Immunol 1997; 41: 209-13.
9. 9. Hall RA, Broom AK, Harnett AC, et al. Immunodominant epitopes on the NS1 protein of Murray Valley encephalitis and Kunjin viruses serve as targets for a blocking ELISA to detect virus-specific antibody in sentinel animal serum. J Virol Methods 1995; 51: 201-10.
10. 10. McMinn PC, Dalgarno L, Weir RC. A comparison of the spread of Murray Valley encephalitis viruses of high or low neuroinvasiveness in the tissues of Swiss mice after peripheral inoculation. Virology 1996; 220: 414-23.
11. 11. Dalgarno L, Trent DW, Strauss JH, et al. Partial nucleotide sequence of Murray Valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. J Mol Biol 1986; 187: 309-23.
12. 12. McMinn PC, Marshall ID, Dalgarno L. Neurovirulence and neuroinvasiveness of Murray Valley encephalitis virus mutants passaged in a monkey kidney cell line. J Gen Virol 1996; 76: 865-72.
13. 13. Lobigs M, Marshall ID, Weir RC, et al. Murray Valley encephalitis virus field strains from Australia and Papua New Guinea: studies on the sequence of the major envelope protein gene and virulence for mice. Virology 1988; 165: 245-55.
14. 14. Hurrelbrink RJ, Nestorowicz A, McMinn PC. Characterisation of infectious Murray Valley encephalitis virus derived from a stably cloned genomic-length cDNA. J Gen Virol 1999; 80: 3115-26.